Home - Gastroenterology Advisor
WEBFDA Alert: Gastroenterology Drug Approvals and New Indications. The FDA approved a biosimilar for inflammatory bowel diseases and issued several new indications for nonerosive GERD, UC, and PFIC.
Clinician Insights on How to Manage Semaglutide-Induced …
WEBSep 8, 2023 · Patients who receive treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist, such as semaglutide, may experience delayed gastric emptying due to the drug’s mechanism of action (MOA). 1 Symptoms may include nausea, vomiting, heartburn, pain, or bloating. 2 However, the symptoms of delayed gastric emptying resulting from GLP-1 receptor agonists may be similar to symptoms of ...
Colonoscopy Prep & Other Quality Indicators From ACG/ASGE
WEB11 hours ago · Quality improvement may depend on the use of multifaceted interventions. The priority quality indicators for colonoscopy include: adenoma detection rate (ADR); sessile serrated lesion detection rate (SSLDR); rate of using recommended screening and surveillance intervals; bowel preparation adequacy rate; and. cecal intubation rate (CIR).
What We Know About Semaglutide Adverse Events and …
WEBSep 1, 2023 · What Are Other Causes of Gastroparesis? Diabetes is the most common underlying cause of gastroparesis and can damage the vagus nerve, leading to impaired muscular function in the stomach and small intestine. 3 Studies show that the 10-year cumulative incidence of diabetic gastroparesis is estimated to be 5.2% among patients with type 1 diabetes and 1% in patients with type 2 diabetes. 4
Gastroenterology CME/CE Courses - Gastroenterology Advisor
WEBOct 3, 2024 · Gastroenterology Continuing Education Courses from myCME. myCME is the premier destination for continuing medical education (CME) and continuing education (CE), committed to providing high-quality, evidence-based, and user-friendly courses tailored to the needs of physicians, nurse practitioners, physician assistants, nurses, pharmacists, and other healthcare professionals across 20+ specialties.
Assessment of Antispasmodics Available in North America for the ...
WEBOct 15, 2021 · Data on the use of antispasmodics available in North America for the treatment of chronic abdominal pain in patients with disorders of gut-brain interaction (DGBI) vary dramatically in safety and efficacy, according to a literature review published in The American Journal of Gastroenterology.Overall, data supporting the use of antispasmodics in this patient population are lacking.
Tradipitant Relieves Nausea, Other Gastroparesis Symptoms
WEBOct 27, 2022 · Tradipitant is efficacious for relieving nausea and other gastroparesis symptoms. Tradipitant significantly improved nausea and other symptoms in patients with idiopathic and diabetic gastroparesis compared with placebo, according to study results presented at the American College of Gastroenterology (ACG) 2022 Annual Meeting, held from October ...
Gastric Intestinal Metaplasia: 2020 AGA Guidelines
WEBMar 12, 2020 · Gastric cancer (GCa) has a significant impact on worldwide morbidity and mortality as the third-leading cause of cancer death in the world. 1 It has traditionally been associated with poor outcomes and limited treatment options by the time patients clinically present. Helicobacter pylori (HP) is the primary cause of intestinal-type noncardia GCa (located in the antrum, body, incisura, or ...
Delayed Endoscopy Linked to Higher Hospitalization in …
WEB4 days ago · The timing of esophagogastroduodenoscopy (EGD) in patients with esophageal food impaction (EFI) does not affect complication rates but is linked to higher hospitalizations when delayed, according to study results published in Digestive Diseases and Sciences.. EFI is a frequent emergency condition, commonly caused by a meat bolus obstruction, with its incidence rising in recent years.
Novel Drug Tradipitant Effective, Safe for Treatment of Nausea in ...
WEBOct 29, 2021 · Tradipitant appears to be an effective and safe treatment option for gastroparesis symptoms, according to research presented at the American College of Gastroenterology (ACG) 2021 Annual Meeting, held from October 22 to 27, 2021, in Las Vegas, Nevada and virtually.